NEW ORLEANS—Sublingual sufentanil (Dsuvia, AcelRx) effectively controlled moderate to severe postoperative pain in spine surgery patients, in an observational study.
There were no apparent adverse events with sublingual administration, but the investigators recognized the need for more prospective research to corroborate their findings.
“I have a personal interest in decreasing postoperative pain, and spine surgery patients often experience significant pain during the first three days